{"": [126, 1238, 0, 1249, 1252, 0], "INTRODUCTION": [1253, 4325, 0], "Design of an accessible protein subunit vaccine": [4335, 7034, 0], "Immunogenicity testing in cynomolgus macaques": [7035, 10049, 0], "Challenge with SARS-CoV-2": [10050, 11932, 0], "RESULTS": [4326, 11932, 1], "DISCUSSION": [11933, 16972, 0], "Production of vaccine samples": [16996, 17242, 0], "SDS\u2013polyacrylamide gel electrophoresis": [17243, 18681, 0], "Competitive ELISA by ACE2-Fc binding": [18682, 19645, 0], "Production of unformulated drug substance": [19646, 20183, 0], "Biolayer interferometry": [20184, 21222, 0], "Negative-stain EM": [21223, 21880, 0], "Immunization of nonhuman primates": [21881, 22945, 0], "ELISA assays": [22946, 24305, 0], "Pseudovirus neutralization assays": [24306, 25997, 0], "ELISPOT assays": [25998, 27352, 0], "Viral load assays": [27353, 29214, 0], "Histopathology": [29215, 30577, 0], "MATERIALS AND METHODS": [16973, 30577, 1]}